At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
EXAS Exact Sciences
Closed Good Friday 03-28 16:00:00 EDT
69.06
+2.18
+3.26%
盘后69.55
+0.49+0.71%
18:56 EDT
High71.62
Low67.18
Vol5.47M
Open67.18
D1 Closing66.88
Amplitude6.64%
Mkt Cap12.54B
Tradable Cap12.40B
Total Shares181.53M
T/O382.48M
T/O Rate3.05%
Tradable Shares179.55M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Exact Sciences gains after data for novel cancer screening test
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.